Multiple Sclerosis Therapeutics Market

Multiple Sclerosis Therapeutics Market is segmented by Product (Monoclonal Antibodies, Immunomodulators, Immunosuppressants, Corticosteroids, Small Molecule Therapies), Application (Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Clinically Isolated Syndrome), Route of Administration (Injectable, Oral, Intravenous), and Region, with forecasts covering the period from 2026 to 2036.